2025 UCLA-UCSF-PCF PSMA and Beyond Conference
March 28-29, 2025
Renee Luskin Conference Center | Los Angeles, CA
Co-Hosted Event
This conference, co-hosted by the University of California, Los Angeles (UCLA) and the University of California, San Francisco (UCSF), with support from the Prostate Cancer Foundation (PCF), will focus on the current and future use of PET imaging and radionuclide therapy, including presentations, panel discussions, and exhibits from invited speakers and stakeholders.

Welcome

The 2025 PSMA and Beyond Conference included presentations and discussions on:

  • PSMA PET Imaging: We will delve into the intricacies of interpreting and reporting PSMA PET imaging, along with an evaluation of the current data supporting its use and its implications for patient care.
  • PSMA-Targeted Radioligand Therapy: Gain insights into patient selection criteria and the optimal management of PSMA-targeted radioligand therapy.
  • Combination Therapy and Future Trials: A critical review of the roles of combination therapy, the potential impact of ongoing and upcoming clinical trials, and the importance of dosimetry.
  • Tumor Boards: Our sessions will utilize tumor boards to spotlight the pivotal role of PSMA imaging and therapy in the context of prostate cancer patients.

Visit our photo gallery for key highlights from our 2024 event!